Petchkrua Wannapha, Little James W, Burns Stephen P, Stiens Steven A, James Jennifer J
Spinal Cord Injury Service, Veterans Affairs Puget Sound Health Care System, Seattle, Washington 98108, USA.
J Spinal Cord Med. 2003 Summer;26(2):116-21. doi: 10.1080/10790268.2003.11753669.
BACKGROUND/OBJECTIVE: Vitamin B12 (or cobalamin) deficiency is well known in geriatric patients, but not in those with spinal cord injury (SCI). This retrospective study describes vitamin B12 deficiency in SCI.
This study utilized a retrospective chart review of patients with SCI who had received serum vitamin B12 testing over the last 10 years.
Probable vitamin B12 deficiency was noted in 16 patients with SCI. Twelve patients had subnormal serum vitamin B12 levels (< 220 pg/mL), whereas 4 patients had low-normal vitamin B12 levels (< 300 pg/mL) with neurologic and/or psychiatric symptoms that improved following vitamin B12 replacement. Classic findings of paresthesias and numbness often were not evident; such findings likely were masked by the pre-existing sensory impairment caused by SCI. Of the 16 SCI patients, 7 were ambulatory; 4 of the 7 presented with deterioration of gait. In addition, 3 of the 16 SCI patients presented with depression and fatigue, 2 had worsening pain, 2 had worsening upper limb weakness, and 2 had memory decline. Of the 12 patients with subnormal serum vitamin B12 levels, 6 were asymptomatic. Classic laboratory findings of low serum vitamin B12, macrocytic red blood cell indices, and megaloblastic anemia were not always present. Anemia was identified in 7 of the 16 patients and macrocytic red blood cells were found in 3 of the 16 patients. Only 1 of the 16 SCI patients had a clear pathophysiologic mechanism to explain the vitamin B12 deficiency (ie, partial gastrectomy); none of the patients were vegetarian. Twelve of the SCI patients appeared to experience clinical benefits from cyanocobalamin replacement (some patients experienced more than 1 benefit), including reversal of anemia (5 patients), improved gait (4 patients), improved mood (3 patients), improved memory (2 patients), reduced pain (2 patients), strength gain (1 patient), and reduced numbness (1 patient).
It is recommended that physicians consider vitamin B12 deficiency in their patients with SCI, particularly in those with neurologic and/or psychiatric symptoms. These symptoms often are reversible if treatment is initiated early.
背景/目的:维生素B12(或钴胺素)缺乏在老年患者中较为常见,但在脊髓损伤(SCI)患者中并不常见。这项回顾性研究描述了SCI患者中的维生素B12缺乏情况。
本研究对过去10年中接受血清维生素B12检测的SCI患者进行了回顾性病历审查。
16例SCI患者被发现可能存在维生素B12缺乏。12例患者血清维生素B12水平低于正常范围(<220 pg/mL),而4例患者维生素B12水平处于低正常范围(<300 pg/mL),伴有神经和/或精神症状,在补充维生素B12后症状改善。感觉异常和麻木等典型表现往往不明显;这些表现可能被SCI导致的原有感觉障碍所掩盖。16例SCI患者中,7例可行走;7例中的4例出现步态恶化。此外,16例SCI患者中有3例出现抑郁和疲劳,2例疼痛加重,2例上肢无力加重,2例记忆力下降。在12例血清维生素B12水平低于正常范围的患者中,6例无症状。血清维生素B12水平低、大红细胞指数和巨幼细胞贫血等典型实验室检查结果并不总是存在。16例患者中有7例被诊断为贫血,16例患者中有3例发现大红细胞。16例SCI患者中只有1例有明确的病理生理机制来解释维生素B12缺乏(即部分胃切除术);所有患者均非素食者。12例SCI患者似乎从氰钴胺素替代治疗中获得了临床益处(一些患者获得了不止一项益处),包括贫血逆转(5例)、步态改善(4例)及情绪改善(3例)、记忆力改善(2例)、疼痛减轻(2例)、力量增加(1例)和麻木减轻(1例)。
建议医生在其SCI患者中考虑维生素B12缺乏情况,特别是那些有神经和/或精神症状的患者。如果早期开始治疗,这些症状通常是可逆的。